02/06/2025
5:45 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025
5:37 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
4:20 PM | Immunovant (Filer)
| Form 424B3 | |
01/24/2025
4:24 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:22 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:23 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
4:16 PM | Immunovant (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/15/2025
3:36 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:30 PM | Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
01/14/2025
7:09 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:07 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for IMVT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. |
12/18/2024
4:01 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2024
4:02 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:11 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:12 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:09 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:08 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
4:11 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2024
4:15 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:42 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
5:49 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
3:21 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:23 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:25 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:27 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:28 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:30 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:31 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
6:40 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:15 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:12 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:19 PM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
3:17 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:19 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:20 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:36 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:38 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:39 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:41 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:42 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
4:04 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Crypto Is Set to Explode in February (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
07/10/2024
4:06 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
4:07 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
5:56 AM | Immunovant (Filer)
| Form DEF 14A | |
06/26/2024
6:01 AM | Immunovant (Filer)
| Form DEFA14A | |
05/29/2024
3:36 PM | Immunovant (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/26/2024
4:22 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
4:18 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
4:20 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:57 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:59 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:01 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:05 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:06 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:18 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:14 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:16 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:54 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:31 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:34 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:37 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:39 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:44 PM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:46 PM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:48 PM | Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:50 PM | Hughes Douglas J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:23 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:27 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:29 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:14 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:16 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:18 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:21 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
